ProThera Biologics
Manufacturing · Rhode Island, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
349 Eddy St, Providence, Rhode Island, 0...Phone Number
(401) 490-9700Website
www.protherabiologics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About ProThera Biologics
ProThera Biologics is focused on developing innovative therapies for the treatment of severe inflammatory diseases by restoring immune regulation. The company is creating a class of human plasma proteins that modulate inflammation pathways to improve patient health. Their flagship product, Inter-alpha inhibitor proteins (IAIP), is a first-in-class medicine aimed at stopping and reversing the course of inflammatory diseases. ProThera Biologics primarily targets patients suffering from life-threatening immune responses that current medications cannot effectively treat.Explore more
ProThera Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ProThera Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
ProThera Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when ProThera Biologics launches new products
Check out if ProThera Biologics is spiking on competitors!
Earning: See what the market has to say on ProThera Biologics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once ProThera Biologics has new funding data
Congratulate Masked Content for being promoted to Masked Content at ProThera Biologics
Check if ProThera Biologics has recently received funding, and reach out quickly before it becomes old news!
Click to see if ProThera Biologics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined ProThera Biologics as Masked Content
Find more new buyers
Compare Similar Companies to ProThera Biologics
Compare insights from companies similar to ProThera Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ProThera Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ProThera Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ProThera Biologics.
ProThera Biologics financials insights
Gather financial insights about ProThera Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Unspecified
$250K
ProThera Biologics Tech Stack
A closer look at the technologies used by ProThera Biologics
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Event
Product Marketing, Events, Learning & Development, Facilities Management, Safety, Health & Safety, Operations
Funding
Project
Spending/Investment
Partnership
Partnership
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ProThera Biologics
Sign Up For FreeTo access detailed company insights
ProThera Biologics is focused on developing innovative therapies for the treatment of severe inflammatory diseases by restoring immune regulation. The company is creating a class of human plasma proteins that modulate inflammation pathways to improve patient health. Their flagship product, Inter-alpha inhibitor proteins (IAIP), is a first-in-class... Read More
